Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: nelarabineFind trials that include: Any drugs shown Results 1-4 of 4 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Risk Classification Schemes in Identifying Better Treatment Options for Children and Adolescents with Acute Lymphoblastic Leukemia Status: ActivePhase: Phase IIIType: TreatmentAge: 1 to 21Trial IDs: 16-001, NCI-2017-00431, NCT03020030 2. Combination Chemotherapy and Nelarabine in Treating Patients with T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status: ActivePhase: Phase IIType: TreatmentAge: Not specifiedTrial IDs: 2006-0328, NCI-2012-01518, NCT00501826 3. Panobinostat, Bortezomib, and Vincristine Sulfate Liposome with Re-induction Therapy in Treating Younger Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoma Status: ActivePhase: Phase IIType: Biomarker/Laboratory analysis, TreatmentAge: 21 and underTrial IDs: TSALV, NCI-2015-00935, NCT02518750 4. CXCR4 Antagonist BL-8040 and Nelarabine in Treating Patients with Relapsed or Refractory T-Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status: ActivePhase: Phase IIType: TreatmentAge: 18 and overTrial IDs: 201606146, NCI-2016-01051, NCT02763384 Select All on Page Start Over
